As well known among hematologists, patients with one of the BCR/ABL-1-Philadelphia chromosome-negative MPNs, i.e., essential thrombocytosis (ET), polycythemia vera (PV) or primary myelofibrosis (PMF), have high incidences of CV-disease (CVD) [5]. Here, ABL1 is linked to essential thrombocythemia.